MG
VCYT icon

Mather Group’s Veracyte VCYT Stock Holding History

Mather Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-175
Closed -$6.01K – 1603
2025
Q3 		$6.01K Buy
+175
New +$5.02K ﹤0.01% 1356
2025
Q2 		– Sell
-130
Closed -$3.85K – 1670
2025
Q1 		$3.85K Buy
+130
New +$4.96K ﹤0.01% 1450
2024
Q3 		– Sell
-130
Closed -$2.88K – 2204
2024
Q2 		$2.88K Hold
130
– – ﹤0.01% 1784
2024
Q1 		$3.58K Buy
+130
New +$3.17K ﹤0.01% 1421

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Mather Group's VCYT Position: Q4 2025 in Review

Mather Group sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 175 shares — an estimated $6.01K sold.

Mather Group first reported a position in VCYT in Q1 2024 and held it in 4 quarters. The position peaked at $6.01K in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Mather Group reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Mather Group sold 175 Veracyte shares in Q4 2025, an estimated $6.01K.
  • Mather Group first reported a position in Veracyte in Q1 2024 and held it in 4 quarters.
  • Mather Group's Veracyte position peaked at $6.01K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Mather Group's 13F filing for Q4 2025, filed 13 Jan 2026.